Cancer Family
Pancreaticobiliary Neoplasm
CI-CAN-00000309Explore in graph →
Non-malignant1,205 active trials11 approved drugs92 evidence items
- NCIt
- C223357
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000309Explore in graph →
Clinical trials
5,005 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02215044 | Dose-finding Study of BI 2536 Administered in Combination With Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic Cancer | terminated | Phase 1 | 12 | Boehringer IngelheimINDUSTRY | 0 | Aug 13, 2014 | clinicaltrials |
| NCT00409292 | RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 33 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 11, 2014 | clinicaltrials |
| NCT01339754 | Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line Chemotherapy(PACT-18) | completed | Phase 2 | 25 | IRCCS San RaffaeleOTHER | 1 | Aug 11, 2014 | clinicaltrials |
| NCT01181245 | A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 1 | 50 | Kyntra BioINDUSTRY | 1 | Aug 6, 2014 | clinicaltrials |
| NCT02209415 | EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer(EUFURO) | unknown | N/A | 182 | Michael Bau MortensenOTHER | 1 | Aug 5, 2014 | clinicaltrials |
| NCT02079363 | DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer | unknown | — | 330 | Aalborg University HospitalOTHER | 1 | Jul 30, 2014 | clinicaltrials |
| NCT00577889 | Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Jul 25, 2014 | clinicaltrials |
| NCT01227018 | PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer | terminated | Phase 2 | 15 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 23, 2014 | clinicaltrials |
| NCT00325494 | A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer | completed | Phase 1 | 24 | MorphotekINDUSTRY | 1 | Jul 17, 2014 | clinicaltrials |
| NCT00225784 | Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer | completed | Phase 2 | 37 | Dartmouth-Hitchcock Medical CenterOTHER | 0 | Jul 16, 2014 | clinicaltrials |
| NCT01015820 | Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer | completed | N/A | 37 | Mayo ClinicOTHER | 1 | Jul 16, 2014 | clinicaltrials |
| NCT02184871 | Next Generation Sequencing in Intrahepatic Cholangiocarcinoma(EtherBil) | unknown | — | 45 | University of BolognaOTHER | 1 | Jul 9, 2014 | clinicaltrials |
| NCT00002947 | Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer | terminated | Phase 1 | 35 | Yale UniversityOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT01862276 | Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma | completed | — | 200 | Kansai Hepatobiliary Oncology GroupNETWORK | 1 | Jul 1, 2014 | clinicaltrials |
| NCT01121562 | Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors | completed | Phase 2 | 12 | PfizerINDUSTRY | 1 | Jun 30, 2014 | clinicaltrials |
| NCT02178280 | Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma | unknown | Phase 1 / Phase 2 | 60 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jun 30, 2014 | clinicaltrials |
| NCT00837876 | Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 37 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT01786850 | Magnetic Resonance-guided High-intensity Focused Ultrasound Treatment of Locally Advanced Pancreatic Cancer | available | — | — | University of Roma La SapienzaOTHER | 1 | Jun 18, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT01134276 | Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers | completed | N/A | 211 | Seoul National University HospitalOTHER | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00679913 | Standardization of Surgery on the Pancreatic Cancer | completed | Phase 3 | 244 | Seoul National University HospitalOTHER | 1 | Jun 6, 2014 | clinicaltrials |
| NCT00968175 | Endoscopic Ultrasound (EUS) Guided-Celiac Plexus Neurolysis (CPN) in Unresectable Pancreatic Cancer | completed | N/A | 60 | University of Alabama at BirminghamOTHER | 1 | Jun 4, 2014 | clinicaltrials |
| NCT01741597 | Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung | withdrawn | Phase 1 | 0 | City of Hope Medical CenterOTHER | 1 | May 30, 2014 | clinicaltrials |
| NCT00331682 | Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer | completed | Phase 2 | 10 | National Cancer Institute (NCI)NIH | 1 | May 28, 2014 | clinicaltrials |
| NCT00356889 | Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors | completed | Phase 2 | 56 | National Cancer Institute (NCI)NIH | 1 | May 28, 2014 | clinicaltrials |
| NCT00002955 | Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas | completed | Phase 2 | 21 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00003085 | Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer | terminated | Phase 2 | 28 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00159471 | Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer. | terminated | N/A | 1 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00183846 | Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers | completed | Phase 1 | 22 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00305877 | Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery | completed | Phase 2 | 137 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT00504192 | A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer | completed | Phase 2 | 40 | Soonchunhyang University HospitalOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT01167816 | Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic Cancer | terminated | Phase 1 | 9 | University of OklahomaOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT02135822 | Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer(NAPGAP) | unknown | Phase 2 | 30 | Chinese PLA General HospitalOTHER | 1 | May 16, 2014 | clinicaltrials |
| NCT00091026 | Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 143 | National Cancer Institute (NCI)NIH | 1 | May 15, 2014 | clinicaltrials |
| NCT00023946 | BMS-247550 in Treating Patients With Liver or Gallbladder Cancer | terminated | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | May 14, 2014 | clinicaltrials |
| NCT00841191 | A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors | completed | Phase 1 / Phase 2 | 84 | Centocor, Inc.INDUSTRY | 5 | May 14, 2014 | clinicaltrials |
| NCT01082809 | Sunitinib as Second-line Treatment in Advanced Biliary Tract Carcinoma | completed | Phase 2 | 59 | Samsung Medical CenterOTHER | 1 | May 14, 2014 | clinicaltrials |
| NCT01025570 | A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer | terminated | Phase 1 | 3 | University of California, San FranciscoOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT00878657 | Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer | terminated | Phase 1 | 8 | Rutgers, The State University of New JerseyOTHER | 1 | May 5, 2014 | clinicaltrials |
| NCT00942682 | Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors | completed | Phase 1 | 21 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 29, 2014 | clinicaltrials |
| NCT00997958 | Study of CellCept for Advanced Pancreatic Cancer | completed | Phase 1 | 12 | Columbia UniversityOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT01020006 | Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine | completed | Phase 2 | 42 | Pharmacyclics LLC.INDUSTRY | 1 | Apr 24, 2014 | clinicaltrials |
| NCT01479803 | Comparison of Two Needles (ProCore vs EchoTip) for the Diagnosis of Pancreatic Solid Mass Under EUS(PICORE) | completed | Phase 3 | 80 | VANBIERVLIETOTHER | 1 | Apr 23, 2014 | clinicaltrials |
| NCT02121366 | EUS-guided Ethanol Ablation of an Insulinoma(EUS) | unknown | N/A | 50 | Guangxi Medical UniversityOTHER | 1 | Apr 23, 2014 | clinicaltrials |
| NCT01381822 | Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors(TH-CR-410) | unknown | Phase 1 | 58 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 21, 2014 | clinicaltrials |
| NCT02118077 | Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer(PC6) | completed | Phase 3 | 154 | Cancer Advances Inc.INDUSTRY | 0 | Apr 21, 2014 | clinicaltrials |
| NCT00044031 | Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma | completed | Phase 3 | 394 | Cancer Advances Inc.INDUSTRY | 0 | Apr 17, 2014 | clinicaltrials |
| NCT01124786 | A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) | completed | Phase 2 | 367 | Clovis Oncology, Inc.INDUSTRY | 15 | Apr 17, 2014 | clinicaltrials |
| NCT00203892 | Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma | completed | Phase 1 / Phase 2 | 23 | University of ChicagoOTHER | 1 | Apr 16, 2014 | clinicaltrials |
| NCT00582699 | Depression, Cytokines and Pancreatic Cancer | completed | — | 80 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 10, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Aug 13, 2014source: clinicaltrials